Altana to sell pharmaceutical division in €4.5bn deal

A Danish drug company owned by private equity firms The Blackstone Group, Nordic Capital and CSFB Private Equity will buy the pharmaceutical division of German company Altana for €4.5bn.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this